Not logged inDabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after de fi nitive surgery: a multicenter, retrospective cohort study (vol 65, 102290, 2023)
Bai, Xue; Shaheen, Ahmed; Grieco, Charlotte; Arienzo, Paolo D.; Mina, Florentia; Czapla, Juliane A.; Lawless, Aleigha R.; Bongiovanni, Eleonora; Santaniello, Umberto; Zappi, Helena; Dulak, Dominika; Williamson, Andrew; Lee, Rebecca; Gupta, Avinash; Li, Caili; Si, Lu; Ubaldi, Martina; Yamazaki, Naoya; Ogata, Dai; Johnson, Rebecca; Park, Benjamin C.; Jung, Seungyeon; Madonna, Gabriele; Hochherz, Juliane; Umeda, Yoshiyasu; Nakamura, Yasuhiro; Gebhardt, Christoffer; Festino, Lucia; Capone, Mariaelena; Ascierto, Paolo Antonio; Johnson, Douglas B.; Lo, Serigne N.; V. Long, Georgina; Menzies, Alexander M.; Namikawa, Kenjiro; Mandala, Mario; Guo, Jun; Lorigan, Paul; Najjar, Yana G.; Haydon, Andrew; Quaglino, Pietro; Boland, Genevieve M.; Sullivan, Ryan J.; Furness, Andrew J. S.; Plummer, Ruth; Flaherty, Keith T. .png)
Share.png)
SaveCD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR SignalingNaoi, Yuto; Morinaga, Takao; Nagasaki, Joji; Ariyasu, Ryo; Ueda, Youki; Yamashita, Kazuo; Zhou, Wenhao; Kawashima, Shusuke; Kawase, Katsushige; Honobe-Tabuchi, Akiko; Ohnuma, Takehiro; Kawamura, Tatsuyoshi; Umeda, Yoshiyasu; Kawahara, Yu; Nakamura, Yasuhiro; Kiniwa, Yukiko; Yamasaki, Osamu; Fukushima, Satoshi; Kawazu, Masahito; Suzuki, Yutaka; Nishikawa, Hiroyoshi; Hanazawa, Toyoyuki; Ando, Mizuo; Inozume, Takashi; Togashi, Yosuke Share Save Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort studyBai, Xue; Shaheen, Ahmed; Grieco, Charlotte; d'Arienzo, Paolo D.; Mina, Florentia; Czapla, Juliane A.; Lawless, Aleigha R.; Bongiovanni, Eleonora; Santaniello, Umberto; Zappi, Helena; Dulak, Dominika; Williamson, Andrew; Lee, Rebecca; Gupta, Avinash; Li, Caili; Si, Lu; Ubaldi, Martina; Yamazaki, Naoya; Ogata, Dai; Johnson, Rebecca; Park, Benjamin C.; Jung, Seungyeon; Madonna, Gabriele; Hochherz, Juliane; Umeda, Yoshiyasu; Nakamura, Yasuhiro; Gebhardt, Christoffer; Festino, Lucia; Capone, Mariaelena; Ascierto, Paolo Antonio; Johnson, Douglas B.; Lo, Serigne N.; Long, Georgina L.; Menzies, Alexander M.; Namikawa, Kenjiro; Mandala, Mario; Guo, Jun; Lorigan, Paul; Najjar, Yana G.; Haydon, Andrew; Quaglino, Pietro; Boland, Genevieve M.; Sullivan, Ryan J.; Furness, Andrew J. S.; Plummer, Ruth; Flaherty, Keith T. Share Save Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patientsNakamura, Yasuhiro; Namikawa, Kenjiro; Kiniwa, Yukiko; Kato, Hiroshi; Yamasaki, Osamu; Yoshikawa, Shusuke; Maekawa, Takeo; Matsushita, Shigeto; Takenouchi, Tatsuya; Inozume, Takashi; Nakai, Yasuo; Fukushima, Satoshi; Saito, Shintaro; Otsuka, Atsushi; Fujimoto, Noriki; Isei, Taiki; Baba, Natsuki; Matsuya, Taisuke; Tanaka, Ryo; Kaneko, Takahide; Onishi, Masazumi; Kuwatsuka, Yutaka; Nagase, Kotaro; Onuma, Takehiro; Nomura, Motoo; Umeda, Yoshiyasu; Yamazaki, Naoya Share Save Adjuvant anti-PD-1 monotherapy benefit varies across different ethnicities and melanoma subtypesBai, X.; Gerstberger, S.; Park, B.; Jung, S.; Johnson, R.; Yamazaki, N.; Ogata, D.; Umeda, Y.; Li, C.; Si, L.; Flaherty, K.; Nakamura, Y.; Namikawa, K.; Long, G. V.; Menzies, A. M.; Johnson, D. B.; Sullivan, R. J.; Boland, G.; Guo, J. Share Save Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)Nakamura, Y.; Namikawa, K.; Yoshikawa, S.; Kiniwa, Y.; Maekawa, T.; Yamasaki, O.; Isei, T.; Matsushita, S.; Nomura, M.; Nakai, Y.; Fukushima, S.; Saito, S.; Takenouchi, T.; Tanaka, R.; Kato, H.; Otsuka, A.; Matsuya, T.; Baba, N.; Nagase, K.; Inozume, T.; Fujimoto, N.; Kuwatsuka, Y.; Onishi, M.; Kaneko, T.; Onuma, T.; Umeda, Y.; Ogata, D.; Takahashi, A.; Otsuka, M.; Teramoto, Y.; Yamazaki, N. Share Save Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter studyUmeda, Yoshiyasu; Yoshikawa, Shusuke; Kiniwa, Yukiko; Maekawa, Takeo; Yamasaki, Osamu; Isei, Taiki; Matsushita, Shigeto; Nomura, Motoo; Nakai, Yasuo; Fukushima, Satoshi; Saito, Shintaro; Takenouchi, Tatsuya; Tanaka, Ryo; Kato, Hiroshi; Otsuka, Atsushi; Matsuya, Taisuke; Baba, Natsuki; Nagase, Kotaro; Inozume, Takashi; Onuma, Takehiro; Kuwatsuka, Yutaka; Fujimoto, Noriki; Kaneko, Takahide; Onishi, Masazumi; Namikawa, Kenjiro; Yamazaki, Naoya; Nakamura, Yasuhiro Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
